| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.5 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.5 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.5 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |